Edit
Neomend
http://www.neomend.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 27.01.2010
Probably Closed
Approximately 150,000 lung resections are performed in the United States every year. Intraoperative air leaks are a primary complication of lung surgery which can lead to other complications such as infections, pneumonia and extended hospitalization. Introducing Progel® Pleural Air Leak Sealant, the only commercially available, FDA approved Pleural Air Leak Sealant in the U.S. Following a multi-center clinical study in the U.S., it was shown that Progel PALS led to a statistically significant reduction in both intraoperative air leaks and hospital stay of nearly two days. Our Proprietary Hydrogel Technology Platform enables Neomend to develop advanced Wound Care products for a variety of applications, including wound sealing, prevention of post-surgical adhesions, and site specific, sustained drug delivery.
Location: United States, California, Irvine
Employees: 51-200
Total raised: $20M
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.08.2011 | Series D | $20M | - |
Mentions in press and media 3
| Date | Title | Description |
| 27.01.2010 | Neomend Closes $30M Funding Round | Neomend, Inc., an Irvine, CA-based company focused on the design, development and commercialization of surgical sealants and adhesion prevention products derived from its ProGEL technology platform, has completed a $30m funding round. The r... |
| 27.01.2010 | Neomend Raises $30M | Irvine-based Neomend, a developer of sealants for the surgical market, announced this morning that it has raised $30M in a Series D funding round. Neomend said the round was led by Clarus Ventures, which contributed $17M of the total round.... |
| 21.05.2009 | NeoMend Finds $2.7M | Irvine-based NeoMend, which is developing wound healing products, disclosed this week via a regulatory filing that it has raised $2.7M out of a $3.5M funding round for the company, consisting of a convertible note along with warrants conver... |